© 2023 Prof. Maciej Banach

Prof. Maciej Banach

Department of Preventive Cardiology and Lipidology, Medical University in Lodz (MUL), Lodz, Poland

Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Liverpool Centre for Cardiovascular Science, Liverpool, United Kingdom

Prof. Maciej Banach

Department of Preventive Cardiology and Lipidology, Medical University in Lodz (MUL), Lodz, Poland

Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Liverpool Centre for Cardiovascular Science, Liverpool, United Kingdom

About me

Short bio and
main abilities

Organizational/administrative experience and skills:

  • Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012), responsible for the EU and bilateral collaboration and science financing.
  • Head for the Bureau for the International Collaboration and Development at the Medical University of Lodz (MUL) (2012-2014).
  • President of the 2nd largest hospital in Poland. – the Polish Mother’s Memorial Hospital – Research Institute (PMMHRI) (2014-2021).
  • Founder and President of the Foundation – Think-Tank “Innovation for Health”, which gathers six main health research institutes and over 40 medical business representatives in Poland with main aim to make innovations in the medical area in Poland.

Group Member/Leader and scientific collaboration:

  • Secretary of the European Atherosclerosis Society (EAS) (2021-2024); Co-Chair of the EAS Lipid Clinic Network (LCN), EAS Advisor for the EU Contacts (2016-2021), FHSC Member.
  • Member of the Scientific and Health Policy Advisory Group of the FH Europe.
  • President of the Polish Lipid Association (PoLA).
  • Founder of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2012-) – a group of over 150 worldwide experts aimed to investigate the most important issues in the field of lipid disorders, hypertension, nutrition and cardiovascular risk. www.lbpmcgroup.com 
  • Founder and President of the International Lipid Expert Panel (ILEP; ilep.eu) (2015-), which has been founded to prepare recommendations in the area of preventive cardiology in the most debatable issues that have not been covered in the existing guidelines.
  • Member of the REPROGRAM Consortium – a group of experts challenging with Covid-19 pandemic, CArdiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO), member of 2 largest worldwide databases – the Global Burden of Disease (GDB) (University of Washington, Seattle, US) and Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC, Imperial College of London, UK).

About me

Short bio and
main abilities

Organizational/administrative experience and skills:

  • Undersecretary of State at the Ministry of Science and Higher Education of the Republic of Poland (2010-2012), responsible for the EU and bilateral collaboration and science financing.
  • Head for the Bureau for the International Collaboration and Development at the Medical University of Lodz (MUL) (2012-2014).
  • President of the 2nd largest hospital in Poland. – the Polish Mother’s Memorial Hospital – Research Institute (PMMHRI) (2014-2021).
  • Founder and President of the Foundation – Think-Tank “Innovation for Health”, which gathers six main health research institutes and over 40 medical business representatives in Poland with main aim to make innovations in the medical area in Poland.

Group Member/Leader and scientific collaboration:

  • Secretary of the European Atherosclerosis Society (EAS) (2021-2024); Co-Chair of the EAS Lipid Clinic Network (LCN), EAS Advisor for the EU Contacts (2016-2021), FHSC Member.
  • Member of the Scientific and Health Policy Advisory Group of the FH Europe.
  • President of the Polish Lipid Association (PoLA).
  • Founder of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2012-) – a group of over 150 worldwide experts aimed to investigate the most important issues in the field of lipid disorders, hypertension, nutrition and cardiovascular risk. www.lbpmcgroup.com 
  • Founder and President of the International Lipid Expert Panel (ILEP; ilep.eu) (2015-), which has been founded to prepare recommendations in the area of preventive cardiology in the most debatable issues that have not been covered in the existing guidelines.
  • Member of the REPROGRAM Consortium – a group of experts challenging with Covid-19 pandemic, CArdiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO), member of 2 largest worldwide databases – the Global Burden of Disease (GDB) (University of Washington, Seattle, US) and Non-Communicable Diseases Risk Factor Collaboration (NCD-RisC, Imperial College of London, UK).

My Research

Prof. Banach has published >1500 original articles, reviews, editorials, and book chapters in the field of dyslipidemia, hypertension, lifestyle, nutrition and nutraceuticals, cardiology, and risk stratification. His combined IF (for only full-text manuscripts) is over 15,000 pts, number of citations (February 2024): 78,540 (acc. Web of Science Core Collection/Publons), 94,484 (acc. SCOPUS), 107,720 (acc. ResearchGate), and 138,257 (acc. Google Scholar), Hirsch’s Index = 97 (WoS/Publons), 100 (SCOPUS), 116 (ResearchGate) and 125 (i10-index: 788) (Google Scholar) – being within 1% the highest cited scientists in the world (in the research area of Clinical Medicine and Pharmacology and Toxicology) according to Essential Science Indicators by Clarivate (with 60 TOP Papers). Prof. Banach is also within top 5 worldwide experts according to ExpertScape in the field statins (3), dyslipidemias (5), cholesterol (3), lipoproteins (5), lipoproteins LDL (5), and HDL cholesterol (4). He is also a 1% Top Reviewer in the areas of Clinical Medicine and Cross-Field (in 2018 and 2019) by Publons/Clarivate and Publons Academy Mentor. 

He is a laureate of several prizes and award, including: Medal on the occasion of the 600th Birthday of Lodz – Ex navicula navis for the most distinguished residents of the city (2023), Doctor Honoris Causa of the University in Zagreb, Croatia (2022), Doctor Honoris Causa of the Medical University in Kosice, Slovak Republic (2020), on Top-100 List of the most influential scientists in medicine in Poland for year 2022 (position 7), 2021 (position 3), 2020 (position 8), 2019 (10), and 2018 (9), Doctor Honoris Causa of the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, Gold Scalpel” Distinction in 2019 for the Innovation (Smart Hospital); Honorary Member of the Romanian Society of Cardiology (2019), Doctor Honoris Causa of the Institute of Cardiology in Kiev (2018), and the University of Medicine and Pharmacy Victor Babes in Timisoara (2017); Gold Honorary Medal for scientific achievements of the Medical Faculty of Medical University in Kosice, Slovak Republic (2018), The Manager of the Year 2016 – Public Entities (2017), “Innovator of the Year – Science Category” by Wprost journal (2017); “Gold Scalpel” Distinction in 2016 for the Innovation; The Personality of the Year 2013 in Poland for the development of science in the field of healthcare – founded by the Heath Manager journal (Termedia Publishing House), Super-Talent in Medicine 2012 Award – the winner of the competition for young scientists in medicine (up to 40) founded by Puls Medycyny journal.

 

MEDIA

Clips from some of my most recent speaking engagements.

Tools to Get to LDL-C Target With Better Adherence: The Experts Share Experiences With New Therapies